Similar Search Results

The effects of product liability exemption in the presence of the FDA

Philipson, Tomas J.; Sun, Eric; Goldman, Dana P. - In: Regulation versus litigation : perspectives from …, (pp. 137-163). 2011

Persistent link: https://www.econbiz.de/10009236132

A reexamination of the costs of medical R&D regulation

Philipson, Tomas J.; Sun, Eric; Goldman, Dana P.; Jena, … - In: Forum for health economics & policy : an evolving … 15 (2012) 3, pp. 132-159

Persistent link: https://www.econbiz.de/10009656216

IP & external consumption effects : generalizations from health care markets

Philipson, Tomas J.; Mechoulan, Stephanie; Jena, Anupam B. - 2006

Persistent link: https://www.econbiz.de/10003278653

The effects of product liability exemption in the presence of the FDA

Philipson, Tomas J.; Sun, Eric C.; Goldman, Dana P. - 2009

Persistent link: https://www.econbiz.de/10003923781

The option value of innovation

Snider, Julia Thornton; Romley, John A.; Vogt, William B.; … - In: Forum for health economics & policy : an evolving … 15 (2012) 2, pp. 1-17

Persistent link: https://www.econbiz.de/10009620435

Innovation and technology adoption in health care markets

Jena, Anupam B.; Philipson, Tomas J. - 2008

Persistent link: https://www.econbiz.de/10003722015

The regulation of medical innovation and pharmaceutical markets

Philipson, Tomas J. - In: The journal of law & economics 45 (2002) 2,2, pp. 583-586

Persistent link: https://www.econbiz.de/10001780824

Sharing RD risk in healthcare via FDA hedges

Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; … - 2017 - This draft: 28 March 2017

The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...

Persistent link: https://www.econbiz.de/10011749446

Sharing R&D risk in healthcare via FDA hedges

Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; … - 2017

Persistent link: https://www.econbiz.de/10011656884

Sharing R&D risk in healthcare via FDA hedges

Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; … - In: The review of corporate finance studies : RCFS 11 (2022) 4, pp. 880-922

Persistent link: https://www.econbiz.de/10013460218